13 citations · 16 across the 8 of their papers we have counts for
3 papers · 1 filter
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
Konstantinos Sechidis, Sophie Sun, Yao Chen +8
This paper proposes a Workflow for Assessing Treatment effeCt Heterogeneity (WATCH) in clinical drug development targeted at clinical trial sponsors. WATCH is designed to address t…
Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
Silvia Calderazzo, Sergey Tarima, Carissa Reid +9
Clinical trials disruption has always represented a non negligible part of the ending of interventional studies. While the SARS-CoV-2 (COVID-19) pandemic has led to an impressive a…
Tutorial: Effective visual communication for the quantitative scientist
Marc Vandemeulebroecke, Mark Baillie, Alison Margolskee +1
Effective visual communication is a core competency for pharmacometricians, statisticians, and more generally any quantitative scientist. It is essential in every step of a quantit…